Modeling and Closed-loop Control of Depth of Anaesthesia
Launched by UNIVERSITY OF LJUBLJANA · Jun 14, 2018
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different anesthetic medications affect the depth of anesthesia during specific surgeries, including eye surgeries and brain surgeries, as well as for patients who need sedation in the intensive care unit (ICU). The goal is to create a new system that can better control how anesthesia is given, making the process safer for patients. Researchers will study how the medications work in the body and develop algorithms, which are like smart instructions, to improve the administration of anesthesia.
To participate in this study, patients should be having vitreoretinal or brain surgery under general anesthesia, or need sedation in the ICU, and must be classified as ASA 1-3 (a way to assess the patient's health before surgery). Those with higher health risks, certain medical conditions, or who are taking specific medications may not be eligible. If you join the trial, you can expect to be part of a process that aims to enhance the safety and effectiveness of anesthesia, contributing to better outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients having vitroretinal surgery in general anaesthesia
- • patients having brain surgery in general anaesthesia
- • patients needing sedation in ICU
- • ASA 1-3
- Exclusion Criteria:
- • ASA \> 3
- • BMI \> 35
- • drug addicts
- • patients taking psychotropic medicines
- • patients taking opioid analgesics (including tramadol)
- • severe psychiatric disease
- • central nervous system disease (except the reason for surgery)
- • arrhythmia affecting or preventing the measurements (e.g. chronic atrial fibrillation)
- • patients that received benzodiazepines
About University Of Ljubljana
The University of Ljubljana, established in 1919, is Slovenia's largest and most prestigious institution of higher education and research. Renowned for its commitment to academic excellence and innovation, the university plays a pivotal role in advancing scientific knowledge and healthcare practices. As a clinical trial sponsor, the University of Ljubljana leverages its extensive expertise and resources across a diverse range of medical disciplines to facilitate robust research initiatives aimed at improving patient outcomes and advancing medical science. With a focus on ethical standards and collaboration, the university is dedicated to fostering a dynamic research environment that supports groundbreaking studies and contributes to the global understanding of health and disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ljubljana, Slovenia
Patients applied
Trial Officials
Gorazd Karer
Principal Investigator
University of Ljubljana
Iztok Potočnik
Principal Investigator
University Medical Centre Ljubljana
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials